Vimarsana
Biggest News Aggregation in the World

Page 21 - Assay Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Assay Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Assay Development Today - Breaking & Trending Today

Determining protein bioactivity using cell-based assays - Vimarsana News

Determining protein bioactivity using cell-based assays

Determining protein bioactivity/functionality using cell-based and biochemical-based assays

Global Drug Discovery Informatics Market Report 2021-2028: Opportunities with the Growing Adoption of In-silico Modeling Tools & Advances in Computing Power - Vimarsana News

Global Drug Discovery Informatics Market Report 2021-2028: Opportunities with the Growing Adoption of In-silico Modeling Tools & Advances in Computing Power

/PRNewswire/ -- The "Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow; By Mode; By Services; By Regions; Segment...

Bio-Rad has launched the SEQuoia RiboDepletion Kit for next-generation sequencing - Vimarsana News

Bio-Rad has launched the SEQuoia RiboDepletion Kit for next-generation sequencing

Product News: Bio-Rad has launched the SEQuoia RiboDepletion Kit for next-generation sequencing 13 May 2021 Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, has announced the launch of the SEQuoia RiboDepletion Kit, which promises to improve assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-seq library.  The SEQuoia RiboDepletion Kit is designed for genomics researchers targeting rare transcripts or working with a limited or degraded sample. The kit can retain RNA transcripts that could be lost when us...

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting - Vimarsana News

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting News provided by Share this article Share this article ROCKVILLE, Md., April 27, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapy's 24 th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://www.asgct.org/. Oral presentations include: Abstract Title: Effects of Sexual Dimorphism and Gen...

The Native Antigen Company Launches SARS-CoV-2 Assay Kit - Vimarsana News

The Native Antigen Company Launches SARS-CoV-2 Assay Kit

The Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, today announced the launch of its SARS-CoV-2 Neutralisation Assay Development Kit. The kit can be used to identify and qualitatively assess the ability of antibodies to neutralize SARS-CoV-2-receptor binding, to support research into variants and their effects on natural and vaccine-induced patient immunity. The easy-to-use kit contains all the key reagents required to measure SARS-...